Children and adults with ADHD show greater improvement in symptoms with viloxazine extended release compared with treatment with atomoxetine, new research suggests.
The US Food and Drug Administration says it is in frequent contact with all manufacturers to monitor the supply of Adderall, which is approved for treating ADHD, and to help resolve this shortage.
A home-based device using transcranial direct current stimulation is safe and effective in treating inattention in adults with attention-deficit/hyperactivity disorder, new research suggests.
Experts are grappling with issues surrounding prescription stimulants in patients with attention deficit hyperactivity disorder and opioid use disorder.